Grant: Operating Grant - Priority Announcement: Ethics
McMaster University
$103,388.00
Public Opinions on the Ethics of Physician-Pharmaceutical Industry Interactions
FY 2008-09
Summary
One of the most potent influences on physician prescribing comes from drug companies. Because the best interests of patients and the drug industry may not be the same, many policy groups in Canada and abroad have developed guidelines for physicians to identify and manage conflict of interest (COI). These are intended to reinforce that physicians' primary ethical responsibility is to their patients and society, not to the industry or the related personal gain. While there have been many papers written, considerable media attention and regular health care professional discussions, about the ethics and acceptability of these interactions, the opinions of the public - lay citizens - have not been sought.
This application describes a detailed survey to focus on the opinions of the Canadian public in terms of: a) their views on the acceptability of various levels of physician-drug industry interactions, b) why interactions are judged to be acceptable versus unacceptable, and c) predictors of these opinions. The proposed research will be accomplished through a large, nation-wide, bilingual telephone survey of 1000 participants, using a newly developed and validated questionnaire. A smaller subset will complete an in-depth second interview aimed to review responses and their underlying reasons in more detail. A survey of this large size provides very precise estimates of opinions, and our analysis will ensure that we have a good understanding of where opinions are similar across the country, where they vary, where they agree with current guidelines and policies on conflict of interest. At study end, we have planned a summary meeting with patient and public representatives, medical professional organization representatives, professional ethicists, and a pharmaceutical industry representative, to review the key findings of the study in light of current COI guidelines and to make recommendations for any policy changes or further research that may be needed.
Department
Program
Operating Grant - Priority Announcement: Ethics
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
186402
Name
Holbrook Anne M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Ethics, Law & Humanities
Projecttitle
Public Opinions on the Ethics of Physician-Pharmaceutical Industry Interactions
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$103,388
Cihrequipment2
$0
Programname2
Operating Grant - Priority Announcement: Ethics
Keyworddelim
Conflict Of Interest; Physician-Pharmaceutical Industry Interactions; Public Opinion; Telephone Survey
Abstract
One of the most potent influences on physician prescribing comes from drug companies. Because the best interests of patients and the drug industry may not be the same, many policy groups in Canada and abroad have developed guidelines for physicians to identify and manage conflict of interest (COI). These are intended to reinforce that physicians' primary ethical responsibility is to their patients and society, not to the industry or the related personal gain. While there have been many papers written, considerable media attention and regular health care professional discussions, about the ethics and acceptability of these interactions, the opinions of the public - lay citizens - have not been sought.
This application describes a detailed survey to focus on the opinions of the Canadian public in terms of: a) their views on the acceptability of various levels of physician-drug industry interactions, b) why interactions are judged to be acceptable versus unacceptable, and c) predictors of these opinions. The proposed research will be accomplished through a large, nation-wide, bilingual telephone survey of 1000 participants, using a newly developed and validated questionnaire. A smaller subset will complete an in-depth second interview aimed to review responses and their underlying reasons in more detail. A survey of this large size provides very precise estimates of opinions, and our analysis will ensure that we have a good understanding of where opinions are similar across the country, where they vary, where they agree with current guidelines and policies on conflict of interest. At study end, we have planned a summary meeting with patient and public representatives, medical professional organization representatives, professional ethicists, and a pharmaceutical industry representative, to review the key findings of the study in light of current COI guidelines and to make recommendations for any policy changes or further research that may be needed.
Competitiondate
200903
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Holbrook, Anne M
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $103,388~ $0~